Phibro Animal Health Corporation

Healthcare

NASDAQ:PAHC · NASDAQ Global Market

Market Cap $1.29B Beta 0.46 P/E (TTM) 13.3

$31.85 +1.23%

+$0.38 today

52W Low $23.57High $60.08

Vol 0.42M · Avg 0.37M

EPS (TTM) $2.35 Div Yield 1.54%Drug Manufacturers - Specialty & Generic

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+31.88%

Period High

$59.33

Period Low

$24.15

Latest

$31.85

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Organon & Co.

NYSE:OGN

$3.53B

Avadel Pharmaceuticals plc

AVDL

$2.12B

Aurinia Pharmaceuticals Inc.

NASDAQ:AUPH

$2.09B

Pediatrix Medical Group, Inc.

NYSE:MD

$1.89B

ANI Pharmaceuticals, Inc.

NASDAQ:ANIP

$1.79B

Alvotech

NASDAQ:ALVO

$1.21B

MannKind Corporation

NASDAQ:MNKD

$1.21B

Evotec SE

NASDAQ:EVO

$921.71M

Tilray Brands, Inc.

NASDAQ:TLRY

$563.33M

BGM Group Ltd.

NASDAQ:BGM

$73.33M

What is the latest PAHC filing?

The latest filing shown is 4 dated Jun 2, 2026.

How many recent filings does PAHC have?

Intrinsic Alpha currently shows 20 recent filings for PAHC.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.